American Cancer Society. Lung Cancer. In: The Cancer Atlas. 2019.

Google Scholar 

Zappa C, Mousa S. Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res. 2016;5(3):288.

Article  PubMed  PubMed Central  CAS  Google Scholar 

National Cancer Institute. Surveillance, epidemiology, and end results program. 2023. Available from: https://seer.cancer.gov/. [Cited 2023 Aug 20].

Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020Aug 13;383(7):640–9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Goldstraw P, Ball D, Jett J, Le Chevalier T, Lim E, Nicholson A, et al. Non-small-cell lung cancer. Lancet (London, England). 2011;378(9804):1727–40.

Article  PubMed  Google Scholar 

Kameyama K, Huang CL, Liu D, Okamoto T, Hayashi E, Yamamoto Y, et al. Problems related to TNM staging: patients with stage III non–small cell lung cancer. J Thorac Cardiovasc Surg. 2002;124(3):503–10.

Article  PubMed  Google Scholar 

IASLC. International association for the study of lung cancer. 2023. Available from: https://www.iaslc.org/. [Cited 2023 Aug 20].

Rami-Porta R, Goldstraw P. Strength and weakness of the new TNM classification for lung cancer. Eur Respir J. 2010;36(2):237–9.

Article  PubMed  CAS  Google Scholar 

Hattori A, Takamochi K, Oh S, Suzuki K. New revisions and current issues in the eighth edition of the TNM classification for non-small cell lung cancer. Jpn J Clin Oncol. 2019;49(1):3–11.

Article  PubMed  Google Scholar 

Bates G, Fox S, Han C, Leek R, Garcia J, Harris A, et al. Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol. 2006;24(34):5373–80.

Article  PubMed  Google Scholar 

Clemente C, Mihm M, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996;77(7):1303–10.

Article  PubMed  CAS  Google Scholar 

Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (New York, NY). 2006;313(5795):1960–4.

Article  CAS  Google Scholar 

Johnson S, Kerr K, Chapman A, Kennedy M, King G, Cockburn J, et al. Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung cancer (Amsterdam, Netherlands). 2000;27(1):27–35.

Article  PubMed  CAS  Google Scholar 

Marrogi A, Munshi A, Merogi A, Ohadike Y, El-Habashi A, Marrogi O, et al. Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer. 1997;74(5):492–501.

Article  PubMed  CAS  Google Scholar 

Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava EKVM. Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer-PubMed. J Pathol. 1997;182(3):318–24.

Article  PubMed  CAS  Google Scholar 

Vesalainen S, Lipponen P, Talja M, Syrjänen K. Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma.  Eur J Cancer (Oxford, England: 1990). 1994;30A(12):1797–803.

CAS  Google Scholar 

Al-Shibli K, Donnem TS, AlSaad S, Persson M, Bremnes R, Busund L. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res. 2008;14(16):5220–7.

Article  PubMed  CAS  Google Scholar 

Fridman W, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306.

Article  PubMed  CAS  Google Scholar 

Donnem T, Kilvaer T, Andersen S, Richardsen E, Paulsen E, Hald S, et al. Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer. Ann Oncol. 2016;27(2):225–32.

Article  PubMed  CAS  Google Scholar 

Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011;29(6):610–8.

Article  PubMed  Google Scholar 

Yang Y, Yang X, Wang Y, Xu J, Shen H, Gou H, et al. Combined consideration of tumor-associated immune cell density and immune checkpoint expression in the peritumoral microenvironment for prognostic stratification of non-small-cell lung cancer patients. Front Immunol. 2022;10:13.

Google Scholar 

Parra ER, Behrens C, Rodriguez-Canales J, Lin H, Mino B, Blando J, et al. Image analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patients. Clin Cancer Res. 2016;22(24):6278–89.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fridman W, Pagès F, Sautès-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298–306.

Article  PubMed  CAS  Google Scholar 

Ganesan A, Johansson M, Ruffell B, Yagui-Beltrán A, Lau J, Jablons D, et al. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. J Immunol. 2013;191(4):2009–17.

Article  PubMed  CAS  Google Scholar 

Platonova S, Cherfils-Vicini J, Damotte D, Crozet L, Vieillard V, Validire P, et al. Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma. Can Res. 2011;71(16):5412–22.

Article  CAS  Google Scholar 

Kim R, Emi M, Tanabe K. Cancer immunoediting from immune surveillance to immune escape. Immunology. 2007;121(1):1.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schreiber R, Old L, Smyth M. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science (New York, NY). 2011;331(6024):1565–70.

Article  CAS  Google Scholar 

Mittal D, Gubin M, Schreiber R, Smyth M. New insights into cancer immunoediting and its three component phases–elimination, equilibrium and escape. Curr Opin Immunol. 2014;27(1):16–25.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dunn G, Old L, Schreiber R. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–48.

Article  PubMed  CAS  Google Scholar 

Schreiber R, Old L, Smyth M. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science (New York, NY). 2011;331(6024):1565–70.

Article  CAS  Google Scholar 

Mittal D, Gubin M, Schreiber R, Smyth M. New insights into cancer immunoediting and its three component phases–elimination, equilibrium and escape. Curr Opin Immunol. 2014;27(1):16–25.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Dunn G, Old L, Schreiber R. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–48.

Article  PubMed  CAS  Google Scholar 

Takeuchi Y, Nishikawa H. Roles of regulatory T cells in cancer immunity. Int Immunol. 2016;28(8):401–9.

Article  PubMed